Are B Vitamins Good for Your Kidneys?

B vitamins play real roles in kidney health, but the relationship is not as simple as “take a supplement and protect your kidneys.” Some B vitamins genuinely help people with kidney disease, particularly by lowering a problematic amino acid called homocysteine and by replacing nutrients lost during dialysis. Yet one of the most striking findings in nephrology research is that high-dose B vitamin supplements actually accelerated kidney decline in a major trial of people with diabetic kidney disease. The answer depends heavily on which B vitamin, what dose, what form, and how much kidney function you still have.

How Your Kidneys Handle B Vitamins

Your kidneys do more than filter waste. They actively reclaim B vitamins from the fluid passing through them, preventing those nutrients from being lost in urine. Specialized receptors in the kidney’s tubules grab filtered vitamin B12 and folate before they can escape, recycling them back into the bloodstream.¹ When kidneys are healthy, this system works efficiently, and most people eating a normal diet keep their B vitamin levels in a reasonable range without supplementation.

When kidney function declines, the picture shifts. People on dialysis face a double hit: the kidneys themselves can no longer reclaim water-soluble vitamins effectively, and the dialysis process washes some of those vitamins directly into the dialysate.² This is why nephrologists have long recommended routine supplementation of several B vitamins for dialysis patients, including thiamine, riboflavin, pyridoxine (B6), pantothenic acid, niacin, and folic acid.³ The goal is straightforward replacement of what dialysis strips away, not pharmacological dosing to “boost” the kidneys.

The Homocysteine Problem in Kidney Disease

Homocysteine is an amino acid your body normally converts into other useful molecules with the help of folate, vitamin B12, and vitamin B6. When kidneys struggle, homocysteine levels climb because the kidneys both metabolize homocysteine and excrete it. High homocysteine is common in chronic kidney disease (CKD) and has long been considered a risk factor for cardiovascular problems.⁴

B vitamin supplementation reliably brings homocysteine levels down. In one study of people with reduced kidney function, about half of those with elevated homocysteine were able to normalize their levels within a year of B vitamin repletion, with folate, B12, and kidney filtration rate being the strongest predictors of improvement.⁵ This biochemical effect is well established. The harder question is whether lowering homocysteine actually translates into fewer heart attacks and longer lives for people with kidney disease, and there the evidence is far less encouraging.

When High-Dose B Vitamins Backfire

The most cautionary data comes from the DIVINe trial, a randomized controlled study of people with diabetic nephropathy. Participants received daily high-dose folic acid, vitamin B6, and vitamin B12 (as cyanocobalamin) or a placebo. Over three years, the supplement group experienced a significantly faster decline in kidney function: their filtration rate dropped by about 16.5 mL/min compared to roughly 10.7 mL/min in the placebo group, a meaningful difference of nearly 6 mL/min.⁶ The supplements successfully lowered homocysteine, but the kidneys got worse anyway. That disconnect shook a lot of assumptions in the field.

A separate large trial in people with end-stage renal disease reinforced the skepticism. High-dose folic acid, B12, and B6 did not reduce total mortality or cardiovascular events compared to placebo.⁷ These findings together suggest that while B vitamins lower homocysteine numbers on paper, the clinical payoff for kidney patients is not guaranteed, and the harm in certain settings is real. This is why blanket high-dose B vitamin supplementation is no longer recommended for people with advanced kidney disease.

Why the Form of B12 Matters

The DIVINe trial used cyanocobalamin, a synthetic form of B12 that contains a cyanide molecule. In healthy people, the tiny amount of cyanide released is easily detoxified. But impaired kidneys struggle to clear cyanide efficiently, and there is growing concern that long-term high-dose cyanocobalamin could contribute to toxicity in people with CKD.⁸ Some researchers now recommend using methylcobalamin or hydroxocobalamin instead, which do not release cyanide during metabolism.

Folic acid, similarly, has been shown to improve blood vessel function in CKD patients through pathways that appear independent of its homocysteine-lowering effect, and it is still considered a reasonable supplementation option in combination with methylcobalamin rather than cyanocobalamin.⁴ The takeaway is not that all B12 supplements are harmful to kidneys, but that the specific form and dose matter a great deal when kidney function is compromised.

Niacin and Phosphate Control in Dialysis

High phosphate levels are a persistent problem in advanced kidney disease. When the kidneys can no longer excrete enough phosphorus, it accumulates in the blood, contributing to bone disease and cardiovascular calcification. The standard approach is phosphate binder medications taken with meals, but niacinamide (a form of vitamin B3) has emerged as an intriguing add-on strategy because it reduces phosphate absorption in the gut.⁹

A randomized crossover trial in Dutch dialysis patients found that 12 weeks of niacinamide supplementation lowered serum phosphate by about 0.6 mg/dL, while the placebo period saw a slight increase.¹⁰ That is a modest but clinically relevant reduction. However, the research community has been cautious about recommending niacinamide broadly, because larger studies on its long-term safety and effectiveness in CKD are still needed. It remains a “promising but not proven” tool for now.

NAD+ Precursors and Acute Kidney Injury

A related but distinct area of B3 research involves NAD+ precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). NAD+ is a molecule cells need for energy production and repair, and its levels drop with age and during kidney injury. In animal experiments, supplementing aged mice with NMN restored NAD+ levels in the kidneys and significantly protected against cisplatin-induced acute kidney injury.¹¹

Early human data is cautiously encouraging. A small safety study gave hospitalized patients with acute kidney injury (AKI) escalating doses of nicotinamide riboside combined with pterostilbene and found that the combination boosted NAD+ levels in blood and was well tolerated at doses up to 1,000 mg twice daily over two days.¹² This study was designed to test safety and show that NAD+ levels actually rose, not to prove clinical benefit. Larger trials testing whether NAD+ boosting prevents lasting kidney damage after AKI are still in the pipeline. The biology is compelling, but it would be premature to treat NMN or NR as a proven kidney therapy.

Thiamine and Diabetic Kidney Disease

Thiamine (B1) looked extremely promising in animal studies. High-dose thiamine and its fat-soluble derivative benfotiamine strongly inhibited the development of early-stage diabetic kidney damage in experimental models, reducing protein leakage into urine and blocking several pathways through which high blood sugar damages kidney tissue.¹³ The effects were dramatic enough that researchers hoped benfotiamine might become a front-line preventive therapy.

Human trials have been disappointing. A double-blind, placebo-controlled study gave benfotiamine to patients with diabetic nephropathy for 12 weeks and found that while thiamine status improved, there was no significant decrease in urinary albumin excretion, the standard marker of kidney damage progression.¹⁴ A companion analysis measuring advanced glycation end-products and markers of blood vessel inflammation likewise came up empty: benfotiamine did not significantly reduce any of them compared to placebo.¹⁵ The gap between the animal results and the human data is frustrating, and longer or larger trials might tell a different story, but at present there is no evidence that thiamine supplements meaningfully protect human kidneys from diabetic damage.

Vitamin B6, Kidney Stones, and Sugar Damage

Vitamin B6 (pyridoxine) has long been thought to reduce the risk of kidney stones because it helps metabolize oxalate, a key component of the most common stone type. But a large pooled analysis following over three million person-years found no association between B6 intake and the risk of developing kidney stones. Comparing the highest and lowest intake categories, the pooled adjusted risk was essentially flat.¹⁶ If you have been taking B6 specifically to prevent stones, the evidence suggests it is not doing much.

Where B6 may prove more useful is in countering advanced glycation end-products (AGEs), the toxic compounds that accumulate when blood sugar stays elevated over time. AGEs contribute to diabetic complications including kidney damage, and B6 vitamers appear to act as scavengers that neutralize reactive oxygen species and glycation intermediates.¹⁷ This protective mechanism is still being worked out, and it has not yet translated into a clinical recommendation for kidney protection, but it represents one of the more interesting biological connections between a B vitamin and kidney-relevant disease pathways.

Biotin and Lab Test Interference

Biotin (B7) presents a different kind of kidney-related problem, one that has nothing to do with kidney biology and everything to do with clinical care. Many of the blood tests used to manage kidney disease, including assays for parathyroid hormone (PTH) and vitamin D, use a biotin-streptavidin chemistry in their design. When a patient taking biotin supplements has high biotin levels in their blood, it throws off the results. In one documented case, a woman on hemodialysis taking 10 mg of biotin daily showed a sudden spike in her vitamin D reading and a dramatic plunge in PTH, both of which returned to baseline once she stopped the supplement.¹⁸

Additional case reports describe similar interference with thyroid and parathyroid function tests in people with chronic kidney failure taking biotin.¹⁹ The danger is not that biotin harms the kidneys directly but that falsely reassuring lab results could lead a doctor to withhold treatment that the patient actually needs, or vice versa. If you have kidney disease and take any supplement containing biotin, your care team needs to know about it before running these tests. High-dose biotin supplements marketed for hair and nail growth are the most common culprits.

After a Kidney Transplant

Kidney transplant recipients occupy an unusual middle ground. They have a new, functioning kidney, but homocysteine levels often remain elevated after transplantation, and cardiovascular disease is still a leading cause of death in this population. Here, B vitamin therapy has shown more consistent benefit than in dialysis patients.

A randomized trial in transplant recipients found that folic acid combined with B12 lowered fasting homocysteine by about 26%, while B6 reduced a different measure of homocysteine, the post-methionine-loading spike, by about 22%. The researchers recommended combining all three for the most complete reduction.²⁰ More compellingly, a study tracking arterial wall thickness found that vitamin supplementation that successfully lowered homocysteine in transplant recipients was associated with a roughly 32% decrease in carotid artery wall thickness, a physical reversal of atherosclerosis progression.²¹

A larger ancillary analysis from the FAVORIT trial confirmed that B vitamin therapy significantly lowered homocysteine in transplant recipients, though it could not normalize levels for nearly half of those treated.²² The transplant setting is one of the clearer cases where B vitamin supplementation does what you would hope: it corrects a measurable deficiency, and there is at least some evidence of a downstream physical benefit.

Riboflavin and Blood Pressure in a Specific Genotype

Riboflavin (B2) has an unusual kidney-adjacent story. About 10% of people worldwide carry a variant of the MTHFR gene (the 677TT genotype) that makes them less efficient at processing folate. This variant is associated with higher blood pressure, and high blood pressure is one of the top drivers of kidney disease. Randomized trials have shown that supplemental riboflavin can lower blood pressure specifically in people with this genotype, independently of whatever blood pressure medications they are already taking.²³

This is a genuinely personalized finding: riboflavin does not lower blood pressure in people without the variant, and standard blood pressure treatments do not fully compensate for the genetic effect. Whether the blood pressure reduction from riboflavin in these individuals translates into measurably less kidney damage over the long term has not been directly tested, but the biological logic is sound. Uncontrolled high blood pressure damages the kidney’s tiny blood vessels over years, and anything that brings it down is, in principle, kidney-protective. Genetic testing for the MTHFR 677TT variant is available and inexpensive, making this one of the more actionable pieces of the B vitamin and kidney puzzle.

What Kidney Patients Actually Get Told

Clinical guidelines from the National Kidney Foundation, updated in 2020, address micronutrient needs in CKD patients, including B vitamins, as part of a broader nutritional framework.²⁴ In practice, the standard approach at most dialysis centers is a daily renal multivitamin that provides modest doses of several B vitamins to replace dialysis losses, without the megadoses that caused problems in the DIVINe trial. These formulations typically exclude vitamin A (which accumulates dangerously in kidney failure) and use conservative amounts of B12.

For people with CKD who are not yet on dialysis, the picture is less standardized. Many nephrologists will check folate and B12 levels and supplement if they are low, particularly in patients with anemia, since B12 and folate deficiencies can compound the anemia that kidney disease already causes. Routine high-dose B vitamin supplementation for “kidney protection,” though, is not supported by current evidence and may be harmful in certain populations, especially those with diabetic nephropathy taking cyanocobalamin. If you are considering B vitamin supplements and you have any degree of kidney impairment, the specific vitamin, its form, and the dose all warrant a conversation with your nephrologist rather than an independent trip to the supplement aisle.